Vaso Corporation

VASO ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $38.3M $22.0M $34.1M $34.9M $32.6M $25.3M $26.3M $26.8M
Accounts Receivable — — — $1.1M $1.1M $1.1M $916.0K —
Inventory $837.0K $827.0K $833.0K $893.0K $939.0K $965.0K $911.0K $1.2M
Total Current Assets $55.2M $51.1M $58.6M $51.9M $50.0M $46.0M $51.2M $43.0M
Property, Plant & Equipment $101.0K $1.2M $121.0K $1.4M $1.8M $1.6M $1.5M $1.6M
Goodwill $1.3M $11.0M $1.2M $15.6M $15.6M $15.6M $1.2M $15.6M
Intangible Assets (Excl. Goodwill) $1.7M $2.2M $1.3M $1.9M $1.8M $1.8M $1.6M $1.5M
Total Assets $85.9M $83.0M $88.3M $84.5M $82.6M $77.9M $82.9M $73.9M
Liabilities
Accounts Payable $673.0K $3.9M $896.0K $3.9M $4.7M $4.4M $4.2M $4.6M
Total Current Liabilities $32.9M $30.6M $36.8M $31.6M $33.0M $30.2M $34.7M $30.2M
Long-Term Debt — — — — — — — —
Total Liabilities $56.7M $54.4M $58.9M $56.2M $56.1M $51.3M $55.2M $48.3M
Stockholders' Equity
Retained Earnings $-32.9M $-33.4M $-32.5M $-33.6M $-35.4M $-35.2M $-34.1M $-36.2M
Total Stockholders' Equity $29.2M $28.6M $29.4M $28.2M $26.5M $26.7M $27.7M $25.7M
← Newer Page 1 of 9 Older →